Alberto L. Horenstein

University of Turin — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

35h-index5.2kcitations98works8.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Calcium signaling and nucleotide metabolism(44), Adenosine and Purinergic Signaling(35), Monoclonal and Polyclonal Antibodies Research(21), Immune Cell Function and Interaction(11), Chronic Lymphocytic Leukemia Research(9)

Publications98 total

Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects
Frontiers in Immunology·2025· 8 citedOpen Access
Immune-regulatory properties carried by human amnion epithelial cells: Focus on the role of HLA-G and adenosinergic ectoenzymes
Human Immunology·2023· 5 cited
MM-324 Effects of Soluble and Microvesicle-Bound Therapeutic Anti-CD38 Antibodies on Immune Effector Cells in Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia·2022
Poster: MM-324 Effects of Soluble and Microvesicle-Bound Therapeutic Anti-CD38 Antibodies on Immune Effector Cells in Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia·2022
CD73/Adenosine Pathway Involvement in the Interaction of Non-Small Cell Lung Cancer Stem Cells and Bone Cells in the Pre-Metastatic Niche
International Journal of Molecular Sciences·2022· 18 citedOpen Access
The Key Role of NAD+ in Anti-Tumor Immune Response: An Update
Frontiers in Immunology·2021· 29 citedOpen Access
CD38 in the age of COVID-19: a medical perspective
Physiological Reviews·2021· 56 citedOpen Access
Molecular dynamics of targeting CD38 in multiple myeloma
British Journal of Haematology·2021· 25 citedOpen Access
The Circular Life of Human CD38: From Basic Science to Clinics and Back
Molecules·2020· 34 citedOpen Access
CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells
Frontiers in Immunology·2020· 40 citedOpen Access
42: Molecular Pathways in Support of Allogenic Human Amnion Epithelial Cell Transplantation for Liver Disease Without Immunosuppression
Transplantation·2019
CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy
Frontiers in Immunology·2019· 66 citedOpen Access
Microvesicles expressing adenosinergic ectoenzymes and their potential role in modulating bone marrow infiltration by neuroblastoma cells
OncoImmunology·2019· 32 citedOpen Access
Ectonucleotidase Expression on Human Amnion Epithelial Cells: Adenosinergic Pathways and Dichotomic Effects on Immune Effector Cell Populations
The Journal of Immunology·2018· 17 cited
CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
Frontiers in Immunology·2018· 171 citedOpen Access
Functional insights into nucleotide-metabolizing ectoenzymes expressed by bone marrow-resident cells in patients with multiple myeloma
Immunology Letters·2018· 10 cited
Abstract 2122: Induction of structural and functional effects of myeloma cells after daratumumab treatment
Cancer Research·2018· 1 cited
Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors
Frontiers in Pharmacology·2018· 17 citedOpen Access
Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD<sup>+</sup>
OncoImmunology·2018· 75 citedOpen Access
Canonical and non-canonical adenosinergic pathways
Immunology Letters·2018· 86 cited
page 1 of 5Next →

Frequent Co-authors

Fabio Malavasi(44), Fabio Morandi(15), Valeria Quarona(13), Antonella Chillemi(13), Ada Funaro(11), Silvia Deaglio(10), Vito Pistoia(9), Nicola Giuliani(8), Enza Ferrero(6), Gianluca Zaccarello(6), Danilo Marimpietri(6), Erika Ortolan(5), Tiziana Vaisitti(5), Massimo Massaia(5), Federica Costa(5), Marina Bolzoni(5), Denise Toscani(5), Angelo Corso Faini(5), Ilaria Durelli(4), Ilaria Roato(4)